Hormonal
Tirzepatide significantly reduces HbA1c levels in individuals with Type 2 Diabetes, with the effect being dose-dependent.
For those managing Type 2 Diabetes, Tirzepatide offers a powerful tool to lower blood sugar levels (HbA1c). It works by helping your pancreas release insulin when needed and stopping the liver from making too much sugar. Like with weight loss, higher doses lead to greater HbA1c reductions. This makes it a viable option for patients who need better glycemic control alongside weight management.
Compared to control, the difference was statistically significant (MD: -1.38, 95%CI: -1.52 to -1.23, P<0.000 01)... 15mg: MD: -1.51, 95%CI: -1.72 to -1.29, P<0.000 01)
Why this rating
Meta-analysis of 9 RCTs.
Source
Efficacy and Safety of Tirzepatide in Overweight and Obese Individuals: A Meta-Analysis of Randomized Controlled Trials
Liya Fu et al. · Medical Research Frontiers · 2026
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →